GCM
TRML

Greenland Capital Management’s Tourmaline Bio TRML Stock Holding History

Greenland Capital Management’s Portfolio TRML Stock Details TRML Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-7,032
Closed -$336K – 413
2025
Q3 		$336K Buy
+7,032
New +$195K 0.03% 246

Greenland Capital Management's TRML Position: Q4 2025 in Review

Greenland Capital Management sold out of Tourmaline Bio (TRML) in Q4 2025, closing a stake of 7,032 shares — an estimated $336K sold.

Greenland Capital Management first reported a position in TRML in Q3 2025 and held it in 1 quarter. The position peaked at $336K in Q3 2025. 0 funds tracked by Wall St. Rank hold TRML as of Q4 2025.

  • Greenland Capital Management reported no remaining Tourmaline Bio position as of Q4 2025 after selling out during the quarter.
  • Greenland Capital Management sold 7,032 Tourmaline Bio shares in Q4 2025, an estimated $336K.
  • Greenland Capital Management first reported a position in Tourmaline Bio in Q3 2025 and held it in 1 quarter.
  • Greenland Capital Management's Tourmaline Bio position peaked at $336K in Q3 2025.
  • 0 funds tracked by Wall St. Rank held Tourmaline Bio as of Q4 2025.

Based on Greenland Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.